Compare CVS Health Corp (CVS) vs Norwegian Cruise Line Holdings Ltd (NCLH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Norwegian Cruise Line Holdings Ltd — how do they compare? CVS Health Corp trades at $88.26 (market cap $112.29B), while Norwegian Cruise Line Holdings Ltd trades at $15.43 (market cap $7.11B). The key difference: CVS Health Corp is far larger — about 15.8× Norwegian Cruise Line Holdings Ltd's market cap, and CVS Health Corp pays a 3.03% dividend while Norwegian Cruise Line Holdings Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Norwegian Cruise Line Holdings Ltd for 68 Days on average.
| CVS | NCLH | |
|---|---|---|
Market Cap | $112.29B | $7.11B |
Volume | 7,763,676 | 22,683,268 |
Sector | Health | Consumer Cyclical |
52-Week High | $110.60 | $25.02 |
52-Week Low | $70.08 | $14.12 |
Typical Hold Time | 83 Days | 68 Days |
Enterprise Value | $174.64B | $21.93B |
Dividend Yield | 3.03% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% on the day, with a bullish technical signal and strong analyst support. Recent earnings beats in Q1 and Q2 2026, alongside steady revenue growth to $402.07B in 2025, highlight operational strength. The stock's valuation appears attractive with a P/E of 23.17 and P/S of 0.27, while a consensus price target of $111.20 suggests significant upside potential. Positive news includes Aetna's 2027 Medicare plan enhancements and a declared quarterly dividend.
The outlook for CVS remains positive, driven by earnings momentum and strategic initiatives in healthcare services. Key risks include reimbursement pressures and regulatory scrutiny, but Wall Street's 85% buy rating and institutional interest underscore confidence. Investors should weigh the stock's growth prospects against margin volatility and debt levels, with the current price offering a favorable entry point relative to targets.
Norwegian Cruise Line Holdings (NCLH) trades at $15.05, down 2.97% on the day, with a neutral technical signal and bearish moving average trend. The company reported strong earnings beats in recent quarters, with Q3 2026 expected to exceed guidance at $0.914 EPS. Fundamentals show robust revenue growth to $9.83B in 2025, though net income margin compressed to 4.3%. Recent news highlights yield pressure and a $950M senior notes offering.
NCLH presents a mixed outlook: valuation appears attractive with a P/E of 9.39 and analyst consensus target of $20.86, implying upside. However, high debt levels, net yield pressures, and volatile cash flows pose risks. The stock offers potential for recovery if operational improvements and pricing strategies stabilize profitability through 2027.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Norwegian Cruise Line Holdings Ltd
Norwegian Cruise Line is the world's third-largest cruise company by berths (at more than 62,000), operating 29 ships across three brands (Norwegian, Oceania, and Regent Seven Seas), offering both freestyle and luxury cruising. The company has redeployed its entire fleet as of May 2022. With eight passenger vessels on order among its brands through 2027 (representing 20,000 incremental berths), Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sailed to around 500 global destinations before the pandemic.
Read more on NCLH →
